Polygeline

DB15879InvestigationalProtein Based Therapies

Polygeline is a medication used for plasma volume expansion.

Resolves to

Compound
UNIICEI2QJ2WARCAS66455-30-9
Clinical / RWD
RxNorm8521
Targets
P02751FN1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
5Marketed productsAcross 2 countries and 2 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Polygeline, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In